Berberine: A novel therapeutic strategy for cancer

Author:

Samadi Parisa12,Sarvarian Parisa12,Gholipour Elham12,Asenjan Karim Shams3,Aghebati‐Maleki Leili4,Motavalli Roza2,Hojjat‐Farsangi Mohammad5,Yousefi Mehdi26ORCID

Affiliation:

1. Student Research Committee Tabriz University of Medical Sciences Tabriz Iran

2. Stem Cell Research Center Tabriz University of Medical Sciences Tabriz Iran

3. Hematology Oncology Research Center Tabriz University of Medical Sciences Tabriz Iran

4. Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran

5. Immune and Gene Therapy Lab, Department of Oncology‐Pathology, Cancer Center Karolinska (CCK) Karolinska University Hospital Solna and Karolinska Institute Stockholm Sweden

6. Aging Research Institute Tabriz University of Medical Sciences Tabriz Iran

Funder

Tabriz University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Genetics,Molecular Biology,Biochemistry

Reference122 articles.

1. Chemotherapy and the war on cancer

2. International Agency for Research on Cancer2019. Available from:http://gco.iarc.fr/.

3. Therapeutic bio‐screening of the bioactive ingredients of Berberis vulgaris;El Sayed M;Funct Plant Sci Biotechnol,2011

4. Integration of traditional Chinese medicine and Western medicine in the era of precision medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3